Anchiano Therapeutics (ANCN) News Today

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Source

Source	Headline
	Rakovina Therapeutics Inc. Announces 2022 Financial Results and Convertible Debenture Financing finance.yahoo.com - May 29 at 2:58 PM
	ITeos Therapeutics Inc Ordinary Shares morningstar.com - May 27 at 6:24 PM
	ENDV Endonovo Therapeutics, Inc. seekingalpha.com - May 20 at 11:36 PM
	Looking Into Oncternal Therapeutics's Return On Capital Employed msn.com - May 18 at 4:33 PM
	Anticompetitive Behavior At United Therapeutics, Regeneron, And The FTC msn.com - May 18 at 4:33 PM
	FTC sues to block Amgen’s acquisition of Horizon Therapeutics msn.com - May 16 at 12:35 PM
	FTC sues to block Amgen acquisition of Horizon Therapeutics msn.com - May 16 at 12:35 PM
	Recap: Abeona Therapeutics Q1 Earnings msn.com - May 12 at 3:14 AM
	TScan Therapeutics More than Doubles Following Deal with Amgen msn.com - May 9 at 12:56 PM
	Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting benzinga.com - April 26 at 7:39 PM
	Perspective Therapeutics, Inc.: Perspective Therapeutics Expands Management Team And Names Andrew Bright as Executive Vice-President of Brachytherapy finanznachrichten.de - April 5 at 7:41 AM
	Cigna's PBM, two others sued in Ohio over drug price fixing - WSJ news.yahoo.com - March 27 at 1:33 PM
	Defence Therapeutics Inc.: Defence Therapeutics and CQDM Fund the Development of a New Cancer Vaccine Platform finanznachrichten.de - February 25 at 11:36 PM
	Voyager Therapeutics Stock (NASDAQ:VYGR), Quotes and News Summary benzinga.com - February 18 at 2:06 AM
	Molina Healthcare, Inc. (NYSE:MOH) Q4 2022 Earnings Call Transcript yahoo.com - February 11 at 8:00 AM
	Revance Therapeutics Stock (NASDAQ:RVNC), Quotes and News Summary benzinga.com - February 10 at 8:59 PM
	Jnana Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference markets.businessinsider.com - January 5 at 10:39 AM
	Down -41.38% in 4 Weeks, Here's Why Allogene Therapeutics (ALLO) Looks Ripe for a Turnaround msn.com - December 29 at 11:05 AM
	Onconova Therapeutics's Return On Capital Employed Insights benzinga.com - December 27 at 10:40 AM
	3 Reasons Amgen Is Buying Horizon — and Why It Wasn’t the Only Company Interested barrons.com - December 13 at 6:39 AM
	Amgen to buy Horizon Therapeutics in $26.4 billion deal msn.com - December 13 at 1:39 AM
	Here's Where Amgen's Loan To Acquire Horizon Therapeutics For $28B Ranks Among M&A Deals In 2022 msn.com - December 12 at 8:38 PM
	Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc markets.businessinsider.com - December 12 at 8:58 AM
	Amgen secures $28.3 billion deal to buy Horizon Therapeutics msn.com - December 12 at 8:58 AM
	Amgen to Buy Horizon Therapeutics in $27.8 Billion Deal msn.com - December 12 at 8:58 AM
	Amgen Is Said to Agree to Buy Horizon at $26 Billion Valuation msn.com - December 12 at 3:58 AM
	Endonovo Names Ira Weisberg President to Guide Global Medical Expansion yahoo.com - November 30 at 10:12 AM
	Roche In Drug Discovery Deal With Jnana Therapeutics markets.businessinsider.com - November 15 at 7:30 PM
	Anthos Therapeutics Launches Second Phase 3 Clinical Trial of Its Dual-acting Factor XI Inhibitor, Abelacimab finance.yahoo.com - August 26 at 1:17 PM
	Global Gene Therapy Market Analysis Report 2022-2026: Adeno-associated Virus Vectors - A Leading Platform for Gene Therapy benzinga.com - August 24 at 9:12 PM
	Alaunos Therapeutics to Present at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference finance.yahoo.com - August 24 at 4:11 PM

Get Anchiano Therapeutics News Delivered to You Automatically

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

ANCN Media Mentions By Week

ANCN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ANCN
News Sentiment
▼
0.00

0.39
▲
Average
Medical
News Sentiment

ANCN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ANCN Articles
This Week
▼
0

2
▲
ANCN Articles
Average Week

Get Anchiano Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ANCN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Anchiano Therapeutics (ANCN) News Today

ANCN Media Mentions By Week

ANCN Media Sentiment

ANCN News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info